Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
Keisuke Enomoto(Tokyo University of Science), Muneki Hotomi(Wakayama Medical University)
Cited by 10
Related Papers
A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1
|Scientific Reports|2019|59
MicroRNA 200b promotes mesenchymal‑to‑epithelial transition in anaplastic thyroid carcinoma
|Oncology Letters|2020|3